NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway | |
He, Fu-Chu; Qin, Lun-Xiu; Zhao, Jing; Dong, Qiong-Zhu; Zhong, Fan; Cai, Li-Li; Qin, Zhao-Yu; Liu, Yang; Lin, Cheng-Zhao | |
刊名 | ONCOTARGET
![]() |
2017 | |
卷号 | 8期号:7 |
ISSN号 | 1949-2553 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3623017 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | He, Fu-Chu,Qin, Lun-Xiu,Zhao, Jing,et al. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway[J]. ONCOTARGET,2017,8(7). |
APA | He, Fu-Chu.,Qin, Lun-Xiu.,Zhao, Jing.,Dong, Qiong-Zhu.,Zhong, Fan.,...&Lin, Cheng-Zhao.(2017).NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.ONCOTARGET,8(7). |
MLA | He, Fu-Chu,et al."NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway".ONCOTARGET 8.7(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论